UBS’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$25K Buy
400
+300
+300% +$17.1K ﹤0.01% 7732
2014
Q2
$5K Sell
100
-500
-83% -$25.1K ﹤0.01% 9573
2014
Q1
$32K Sell
600
-1,200
-67% -$61.5K ﹤0.01% 7461
2013
Q4
$81K Buy
1,800
+700
+64% +$32K ﹤0.01% 6333
2013
Q3
$55K Buy
1,100
+200
+22% +$9.79K ﹤0.01% 6754
2013
Q2
$41K Buy
+900
New +$39.5K ﹤0.01% 6990

Other funds holding PRXL

UBS's PRXL Position: Q3 2014 in Review

UBS increased its Parexel International Corp (PRXL) stake by 28% in Q3 2014, buying an estimated $196K and bringing the position to 15,582 shares worth $983K. The position accounts for ﹤0.01% of the portfolio, ranked #3612.

UBS first reported a position in PRXL in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.6M in Q1 2014. 271 funds tracked by Wall St. Rank hold PRXL as of Q3 2014.

  • UBS held 15,582 shares of Parexel International Corp worth $983K as of Q3 2014.
  • UBS bought 3,435 Parexel International Corp shares in Q3 2014, an estimated $196K.
  • Parexel International Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3612 holding.
  • UBS first reported a position in Parexel International Corp in Q2 2013 and has held it in 6 quarters since.
  • UBS's Parexel International Corp position peaked at $1.6M in Q1 2014.
  • 271 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.